| Literature DB >> 10085294 |
R K Miller1, D Matheos, M D Rose.
Abstract
In the yeast Saccharomyces cerevisiae, positioning of the mitotic spindle requires both the cytoplasmic microtubules and actin. Kar9p is a novel cortical protein that is required for the correct position of the mitotic spindle and the orientation of the cytoplasmic microtubules. Green fluorescent protein (GFP)- Kar9p localizes to a single spot at the tip of the growing bud and the mating projection. However, the cortical localization of Kar9p does not require microtubules (Miller, R.K., and M.D. Rose. 1998. J. Cell Biol. 140: 377), suggesting that Kar9p interacts with other proteins at the cortex. To investigate Kar9p's cortical interactions, we treated cells with the actin-depolymerizing drug, latrunculin-A. In both shmoos and mitotic cells, Kar9p's cortical localization was completely dependent on polymerized actin. Kar9p localization was also altered by mutations in four genes, spa2Delta, pea2Delta, bud6Delta, and bni1Delta, required for normal polarization and actin cytoskeleton functions and, of these, bni1Delta affected Kar9p localization most severely. Like kar9Delta, bni1Delta mutants exhibited nuclear positioning defects during mitosis and in shmoos. Furthermore, like kar9Delta, the bni1Delta mutant exhibited misoriented cytoplasmic microtubules in shmoos. Genetic analysis placed BNI1 in the KAR9 pathway for nuclear migration. However, analysis of kar9Delta bni1Delta double mutants suggested that Kar9p retained some function in bni1Delta mitotic cells. Unlike the polarization mutants, kar9Delta shmoos had a normal morphology and diploids budded in the correct bipolar pattern. Furthermore, Bni1p localized normally in kar9Delta. We conclude that Kar9p's function is specific for cytoplasmic microtubule orientation and that Kar9p's role in nuclear positioning is to coordinate the interactions between the actin and microtubule networks.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10085294 PMCID: PMC2148208 DOI: 10.1083/jcb.144.5.963
Source DB: PubMed Journal: J Cell Biol ISSN: 0021-9525 Impact factor: 10.539
Yeast Strains
| Strain | Genotype | Source | ||
|---|---|---|---|---|
| MS52 |
| |||
| MS1556 |
| |||
| MS4062 |
| |||
| MS4306 |
| |||
| MS4316 |
| |||
| MS4903 |
| |||
| MS5208 |
| |||
| MS5209 |
| |||
| MS5215 |
| |||
| MS5340 |
| |||
| MS5229 |
| |||
| MS5230 |
| |||
| MS5429 |
| |||
| MS5665 |
| |||
| MS5794 |
| |||
| MS5849 |
| |||
| MS5850 |
| |||
| MS6127 |
| |||
|
| ||||
| MS6148 |
| |||
| MS6149 |
| |||
| MS6151 |
| |||
| MS6154 |
| |||
| MS6161 |
| |||
| MS6162 |
| |||
| MS6163 |
| |||
| MS6164 |
| |||
| MS6165 |
| |||
| MS6166 |
| |||
| JY427 |
| Fink | ||
| JY424 |
| Fink | ||
| MY3722 |
| |||
| MY3371 |
| Winston | ||
| Y306 |
| Bender | ||
| Y373 |
| Bender | ||
| Y897 |
| Bender | ||
| YEF1002 |
| Bi/Pringle | ||
| DDY76 |
| Drubin | ||
| DDY495 |
| Drubin | ||
| DBY7055 |
| Amberg |
All yeast strains were constructed for this study, unless otherwise indicated.
Plasmids and Bacterial Strains
| Strain | Genotype/description | Source | ||
|---|---|---|---|---|
| pMR3465 | P | Rose | ||
| p321 |
| Boone | ||
| p210 |
| Snyder | ||
| pNV44 |
| Herskowitz | ||
| pRS403 |
| Hieter | ||
| pMR4348 | P | Boone | ||
| /p1955 |
Figure 1In both shmoos and cells, Kar9p localization is actin dependent. Wild-type shmoos and mitotic cells (MS1556) expressing GFP-Kar9p (pMR3465) (2–2.5 h) were treated with LAT-A for 10 min, as described in Materials and Methods. The percentage of mitotic cells and shmoos exhibiting each pattern of GFP-Kar9p localization was determined after microscopic examination. Only mitotic cells with medium to large buds were scored. n > 100 cells for each experimental condition. The panel depicting the example of the cortical dot also shows a line of GFP-Kar9p localization extending from it. Approximately 10% of cells with cortical dots also show the line pattern. Previous work (Miller and Rose, 1998) has shown that the line represents microtubule association.
Figure 2GFP-Kar9p shows aberrant localization in polarization mutants. GFP-Kar9p expression was induced in shmoos by the simultaneous addition of alpha factor and galactose to early exponentially growing cultures. Both shmoos and mitotically dividing cells were induced for GFP-Kar9p expression for 2–2.5 h by the addition of galactose (2%). The following strains containing P-GFP-KAR9 LEU2 CEN4 ARS1 AMP (pMR3465) were used: wild type (MS1556), spa2Δ (MS5209 and MS5208), pea2Δ (MS5229 and MS5230), bni1Δ (MS5215 and MS5340), and bud6Δ (MS5850). Cells were fixed with formaldehyde and scored for GFP-Kar9p localization patterns by microscopy. In the shmoo assay, only cells with a defined shmoo projection were scored.
Nuclear Migration Defects of Mutants
| Strain |
| Nuclei in large-budded cells | Σ % LB abnormal | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bud size | Percent normal | Percent abnormal | ||||||||||||||||||||||
|
| ||||||||||||||||||||||||
| Wild type | 501 | 35 | 23 | 22 | 20 | 46 | 15 | 34 | 2 | 2 | 0 | 4 | ||||||||||||
|
| 301 | 25 | 16 | 20 | 40 | 29 | 6 | 16 | 15 | 17 | 18 | 50 | ||||||||||||
|
| 351 | 27 | 20 | 22 | 31 | 48 | 21 | 23 | 3 | 4 | 1 | 8 | ||||||||||||
|
| 310 | 29 | 22 | 24 | 25 | 51 | 13 | 27 | 3 | 4 | 1 | 8 | ||||||||||||
|
| 333 | 28 | 14 | 23 | 36 | 46 | 23 | 26 | 2 | 2 | 4 | 8 | ||||||||||||
|
| 404 | 35 | 22 | 18 | 25 | 56 | 5 | 6 | 4 | 23 | 5 | 32 | ||||||||||||
The percentage of nuclear positioning defects in mutant cultures. Cultures of wild type (MS1556), kar9Δ (MS4306), bni1Δ (MS5215), bud6Δ (MS5849), spa2Δ (MS5208), and pea2Δ (MS5229) were grown to early exponential phase at 30°C. The position of nuclear DNA was visualized by DAPI to visualize nuclear material. Each strain was scored for bud size as unbudded, small, medium, or large budded. Large-budded cells were also examined for their nuclear phenotype and scored as either normal or abnormal (nuclear morphology corresponding to the phenotypes schematically depicted). The percentages of bud size are from the total cells counted (n > 300). The percentages for the nuclear phenotypes are derived from the percent of large-budded cells. The percentage of defects in large-budded cells is shown in the Σ % LB abnormal column. A representative experiment is shown.
Nuclear Position in Mutant Shmoos
|
| ||||||
|---|---|---|---|---|---|---|
| Nucleus | In/at neck | In center | At bottom | |||
| Wild type | 66 | 34 | 0 | |||
|
| 1 | 71 | 28 | |||
|
| 85 | 15 | 0 | |||
|
| 83 | 15 | 2 | |||
|
| 42 | 58 | 0 | |||
|
| 15 | 72 | 13 | |||
The percentage of nuclear positioning defects in mutant shmoos. Wild type (MS1556) and mutant strains kar9Δ (MS4306), spa2Δ (MS5208), pea2Δ (MS5229, bud6Δ (MS5849), and bni1Δ (MS5215) were induced to form shmoos with alpha factor for 2 h. Cells were fixed, stained with DAPI, and then scored for nuclear position. n = 100 cells for each strain.
Figure 3Microtubule orientation in shmoos. Wild-type (MS1556) and mutant strains kar9Δ (MS4306), spa2Δ (MS5208), pea2Δ (MS5229), bud6Δ (MS5849), and bni1Δ (MS5215) were induced to form shmoos with alpha factor for 2 h. Cells were then prepared for indirect immunofluorescence as described in Materials and Methods.
Microtubule Orientation in kar9Δ bni1Δ Double Mutants
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
| Nucleus | cMTs extending into bud | cMTs to neck | cMTs not extending into bud | No cMTs | ||||
| Wild type | 90 | 0 | 3 | 7 | ||||
|
| 31 | 17 | 48 | 4 | ||||
|
| 79 | 8 | 7 | 6 | ||||
|
| 41 | 10 | 49 | 1 |
Kar9p is functioning in a bni1Δ mutant. In cells stained with DAPI and antitubulin, the percentage of cells with microtubule orientation defects was scored in cells with anaphase within the mother cell. The following strains derived from MS6127 were used: wild-type strain (MS6148), kar9Δ (MS6165), bni1Δ (MS6164), and kar9Δ bni1Δ strains (MS6151, MS6144, MS6162, MS6163). Cells were grown to early exponential phase at 30°C, and then fixed for indirect immunofluorescence using the tubulin antibody, YOL1/34. n = 100 cells each for wild-type, bni1Δ, and kar9Δ strains. Values for kar9Δ bni1Δ are the average obtained from analysis of four independent strains (n = 402).
Nuclear Migration Defects of Mutants
| Strain | Large-budded cells | Unbudded cells | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % Normal | % Abnormal | % Normal | % Abnormal | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
| Σ |
|
|
|
| Σ | |||||||||||||||
| Wild type | 103 | 60 | 15 | 23 | 2 | 0 | 0 | 0 | 2 | 231 | 100 | 0 | 0 | 0 | ||||||||||||||
|
| 100 | 52 | 8 | 7 | 11 | 6 | 15 | 1 | 33 | 174 | 96 | 2 | 2 | 4 | ||||||||||||||
|
| 107 | 64 | 3 | 16 | 5 | 12 | 1 | 0 | 18 | 378 | 99 | 0.25 | 0.25 | 0.5 | ||||||||||||||
|
| 594 | 45 | 3 | 5 | 11 | 14 | 20 | 2 | 47 | 1,037 | 78 | 9 | 13 | 22 | ||||||||||||||
The bni1Δ kar9Δ double mutant exhibits a slightly worse phenotype than the single mutants alone. The wild-type strain (MS6148), bni1Δ (MS6164), kar9Δ (MS6165), and five bni1Δ kar9Δ strains (MS6166, MS6161, MS6154, MS6149, and MS6151) were grown to early exponential phase, zymolyased, stained with DAPI, and prepared as described in Table V. No obvious nuclear positioning defect was observed in small- and medium-budded cells of wild-type, bni1Δ, or kar9Δ strains. In contrast, 4% of medium-budded bni1Δ kar9Δ cells contained two nuclei (n = 195, data not shown). Σ, the sum of abnormal phenotypes.
Viability of Mutants in Combination with kar9Δ or dhc1Δ
| Mutant combination | Tetrads analyzed | Number of predicted mutants | Mutants dead or forming microcolonies | Viability of double or triple mutant | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. |
| 8 | 7 | 0% | Viable | |||||
| 2. |
| 13 | 16 | 0% | Viable | |||||
| 3. |
| 27 | 28 | 0% | Viable | |||||
| 4. |
| 11 | 8 | 0% | Viable | |||||
| 5. |
| 23 | 28 | 11% | Viable | |||||
| 6. |
| 23 | 18 | 11% | Viable | |||||
| 7. |
| 18 | 18 | 6% | Viable | |||||
| 8. |
| 24 | 26 | 8% | Viable | |||||
| 9. |
| 19 | 20 | 100% | SL | |||||
| 10. |
| 23 | 20 | 5% | Viable | |||||
| 11. |
| 38 | 14 | 0% | Viable | |||||
| 12. |
| 38 | 19 | 5% | Viable | |||||
Standard meiotic crosses were used to construct the indicated double mutants. The size of the colonies was scored 2–3 d after germination at 30°C. SL indicates that synthetic lethality was observed.
The bud6Δ dhc1Δ double mutant exhibited a decreased growth rate. The following crosses were carried out to create the indicated double mutants: 1. spa2Δ kar9Δ, MS5208 × MS4062; 2. pea2Δ kar9Δ, MS5229 × MS4062; 3. bud6Δ kar9Δ, MS5849 × MS4316; 4. bni1Δ kar9Δ, MS5215 × MS4062; 5. bnr1Δ kar9Δ, MS5794 × MS4316; 6. spa2Δ dhc1Δ, MS5208 × MS5429; 7. pea2Δ dhc1Δ, MS5229 × MS5429; 8. bud6Δ dhc1Δ, MS5849 × MS5429; 9. bni1Δ dhc1Δ, MS5215 × MS5429; 10. bnr1Δ dhc1Δ, MS5794 × MS5429; 11. bni1Δ kip3Δ, MS5665 × MS5215; 12. bni1Δ kar9Δ kip3Δ, MS5665 × MS5215.